Medical Letter on the CDC and FDA

Public Health - Research from Veterans Health Administration in the area of public health described

Radiology - New radiology study results from Hacettepe University, Department of Radiology described

Regulatory Actions - Researchers from National Institutes of Health, Department of Public Health publish new studies and findings in the area of regulatory actions

Respiratory Disease Epidemiology - New respiratory disease epidemiology study results reported from Agricultural Research Service

Smoking - Research reports from Heidelberg University, Institute of Public Health provide new insights into smoking

Tigecycline Therapy - Research from Northwestern Memorial Hospital, Department of Pharmacy yields new findings on tigecycline therapy

Vaccines - Studies from G. Lippi and co-researchers in the area of vaccines published

Vomiting Therapy - New vomiting therapy study results from University of Wisconsin described

West Nile Virus - Researchers at Centers for Disease Control and Prevention target west nile virus

Access Pharmaceuticals, Inc. - Access Pharma's Korean Partner Gains Marketing Approval for MuGard

Acorda Therapeutics, Inc. - Acorda Therapeutics Announces Filing of Patent Extension Applications for AMPYRA(TM) dalfampridine

Adventrx Pharmaceuticals, Inc. - ADVENTRX Sets Meeting With FDA to Discuss ANX-530 NDA

AGA Medical Holdings, Inc. - AGA Medical Receives Conditional IDE Approval from FDA to Study Use of AMPLATZER(R) Cardiac Plug to Close the Left Atrial Appendage

Agilent Technologies Inc. - TRADE NEWS: Agilent Microarray Manufacturing Achieves ISO 13485 Compliance; Cytogenetics Platform Poised to Pursue FDA 510k Clearance

American Academy of Dermatology Association - American Academy of Dermatology Association Testifies at FDA Hearing on Indoor Tanning Devices

Annuloplasty - ATS Medical Receives Approval to Commercialize the ATS Simulus Annuloplasty Products in Canada

APP Pharmaceuticals, Inc. - APP Pharmaceuticals Receives Approval for Indomethacin for Injection

Aspyra, Inc. - Aspyra Receives FDA Clearance to Market AccessNET PACS with Mammography Viewing

BayBio - Historic Health Care Reform Bill Good for Bay Area Life Science Industry

Biomass Advisors - One Billion Gallons in Camelina Biofuel by 2025

blu Cigs - blu Cigs Announces Exclusive Partnership with Johnson Creek Enterprises, LLC

BSD Medical Corporation - BSD Medical Files FDA 510k Submission to Market Phase II MicroThermX Ablation System

ChemGenex Pharmaceuticals Limited - U.S. Food and Drug Administration's Oncologic Drug Advisory Committee Recommends ChemGenex Validate a Diagnostic Prior to Approval of OMAPRO(TM) in Chronic Myeloid Leukemia Patients with T315I Mutation

Clinical Data, Inc. - Clinical Data, Inc. Submits New Drug Application for Vilazodone for the Treatment of Major Depressive Disorder

Coalition for 21st Century Medicine - Coalition for 21st Century Medicine Applauds NIH Genetic Testing Registry

Collegium Pharmaceutical, Inc. - Collegium Pharmaceutical Inc. Announces Filing of IND for Second Chronic Pain Product Using DETERx(TM) Tamper-Resistant, Extended Release Technology

CombinatoRx, Incorporated - CombinatoRx Reports Financial Results for the Fourth Quarter and Year-End 2009

Custom Spine - Custom Spine Receives FDA Clearance for PATHWAY ACIF

CyDex Pharmaceuticals, Inc. - CyDex Pharmaceuticals Initiates Dosing for Phase 2A Oncology Drug Trial

Duke University - People are living longer and healthier -- now what?

EVOFEM Inc. - EVOFEM Announces Distribution Deal for Instead Softcup with Duane Reade Drugstores

ExpertSource - Experts Available to Discuss New Way to Treat Inoperable Lung Cancer; Study Shows Targeted Radiation Therapy May Help Control Non-Small-Cell Lung Cancer Tumors

Galderma Laboratories, L.P. - Galderma Received FDA Approval of Differin adapalene Lotion, 0.1%, the First Retinoid Available in Lotion Formulation

Genzyme Corporation - Genzyme Announces FDA Enforcement Action Regarding Allston Plant

GlaxoSmithKline - GlaxoSmithKline Statement on New Information Relating to Manufacture of Rotarix Rotavirus Vaccine

Guided Therapeutics - Guided Therapeutics' LightTouch Cervical Scan Detected Disease Up to Two Years Earlier Than Pap, HPV and Biopsy in FDA Pivotal Clinical Trial

Guided Therapeutics, Inc. - Guided Therapeutics LightTouch Cervical Scan FDA Clinical Trial Indicates Adolescent's Risk for Cervical Disease on Par with Adult Women

Image Solutions, Inc. - ISI and Cadence Pharmaceuticals Collaborate to Leverage Software-as-a-Service Technology

Inhibitex, Inc. - Inhibitex Reports Fourth Quarter and Calendar Year 2009 Financial Results and Corporate Highlights

IntelligentMDx - IntelligentMDx IMDx Receives FDA Emergency Use Authorization EUA for First 2009 H1N1 Influenza Assay to be Authorized for Use on Multiple Instruments in Commercial Laboratories

InterMune, Inc. - The European Medicines Agency Completes Validation Stage for InterMune's Marketing Authorization Application for pirfenidone

Intertek - Intertek Introduces 10 Day 510k Review Program

L.J. Star Incorporated - L.J. Star Standardizes on Gylon(R) Gaskets for Sight Glasses and Sight Flow Indicators

LEEP, Inc. - LEEP, Inc. Announces European Order

LiftSeat Corporation - LiftSeat Named Exclusive U.S. Distributor of Hygie Hygienic Cover System

Lorillard, Inc. - Lorillard Tobacco's Principal Scientist to Represent Tobacco Industry on FDA's Scientific Advisory Committee

Lupin Pharmaceuticals, Inc. - Lupin Receives FDA Tentative Approval for Eszopiclone Tablets

Magellan Biosciences, Inc. - FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre In Vitro Diagnostic IVD MIC Susceptibility Plates: Minocycline and Telavancin Used to Treat MRSA and Other Infections; and Tigecycline, Now Cleared fo

Medtronic, Inc. - Medtronic Receives FDA Panel's Unanimous Recommendation for Approval of Revo MRI(TM) SureScan(TM) Pacing System

Meridian Bioscience, Inc. - Meridian Bioscience Submits New illumigene(TM) Molecular C. difficile Test to U.S. FDA for Marketing Clearance

Merix Pharmaceutical Corp. - Merix Pharmaceutical Corp. Unveils First Over the Counter Genital Herpes Treatment

MiddleBrook Pharmaceuticals, Inc. - MiddleBrook Pharmaceuticals Announces Board of Directors Resignations

Milestone Scientific Inc. - Milestone Scientific Issues Update on New Business Activities in China

Minnesota Institute of Public Health - New Ads Warn About Providing Alcohol to Minors

Mundipharma - Levact(R) (bendamustine) Recommended for Approval in

National Wooden Pallet and Container Association - Tylenol Recall: the True Root Cause Begs Further Examination

NIH/National Institute of Allergy and Infectious Diseases - 1918 and 2009 pandemic influenza viruses lack a sugar topping

NMT Medical, Inc. - NMT Medical Announces Fourth-Quarter and Year-End 2009 Financial Results

Non-Hodgkin Lymphoma - CTI Provides Update on FDA Advisory Committee Meeting on Pixantrone for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Nuvilex, Inc. - Nuvilex, Inc. Reports Doctors Findings that Homeopathic Remedies Successfully Treated Swine Flu in Mexico City

Oncothyreon Inc. - Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono

OrSense Ltd. - OrSense Receives U.S. FDA Approval for NMB-200MP Non-Invasive Oximetry Monitoring System

PanGenex Corporation - PanGenex Corporation Expands Scientific Advisory Board with Two New Appointments

Parkinson Disease - Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease

Pernix Therapeutics Holdings, Inc. - Pernix Announces CEDAX(R) Acquisition

PPD, Inc. - PPD Strengthens Global Risk Management Services with Appointment of REMS Expert

Pre-Trials Research - SRI International Awarded National Institutes of Health Preclinical Services Contract

Prisym Id - PRISYM ID's Medica Greatly Simplifies FDA and MHRA Compliance

Purdue University - Study: Federal funds support health depts., but leadership is key

Riverain Medical - Riverain Medical Receives FDA Clearance for SoftView Enhanced Chest Imaging

Salix Pharmaceuticals, Ltd. - FDA Approves XIFAXAN(R) 550 MG Tablets for Reduction in Risk of Overt Hepatic Encephalopathy HE Recurrence

Salix Pharmaceuticals, Ltd. - XIFAXAN(R) 550 mg Tablets Demonstrate Significant Reduction of Risk for Episodes of Overt Hepatic Encephalopathy According to Findings Published in the New England Journal of Medicine

Simcere Pharmaceutical Group - Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study

Small Cell Lung Cancer - Poniard Pharmaceuticals Provides Strategic Update on Picoplatin Development Program

Society for Adolescent Medicine - Phoenix Suns' Grant Hill Joins Vaccines for Teens Educational Campaign to Help Local Teens Take Their Best Shot at Health

Society for Healthcare Epidemiology of America - France's national program to reduce HAIs reports important successes; uses mandatory reporting

Society for Healthcare Epidemiology of America - Researchers find infrared thermal detection systems useful for patient screening

SpectraScience, Inc. - SpectraScience Has Second Unannounced Inspection by FDA

St. Jude Medical, Inc. - St. Jude Medical Receives Australian TGA Regulatory and Reimbursement Approval for World's Smallest Rechargeable Deep Brain Stimulator for Parkinson's Disease

Stryker Corporation - Stryker Announces Resolution of FDA Warning Letter Related to Its Mahwah, New Jersey Manufacturing Facility

Sunwin International and WILD Flavors, Inc. - Sunwin International and WILD Flavors, Inc. Receive GRAS Letters of No Objection from FDA Supporting the Safety of Multiple Sunwin Stevia Extracts

Transcept Pharmaceuticals, Inc. - Transcept Pharmaceuticals Updates Plan for Intermezzo NDA Resubmission Following Teleconference With the FDA

U.S. Food and Drug Administration - Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk

U.S. Food and Drug Administration - FDA Approves New Use of Xifaxan for Patients with Liver Disease

U.S. Food and Drug Administration - FDA Warns About Increased Risk of Muscle Injury with Zocor

University of California - Davis - Health System - Walnuts slow prostate tumors in mice

University of Pittsburgh Schools of the Health Sciences - Multifunctional polymer neutralizes both biological and chemical weapons

ViroPharma Incorporated - ViroPharma Announces Acceptance of Cinryze C1 Esterase Inhibitor [Human] Marketing Authorization Application MAA by European Medicines Agency EMA

Vivos - Vivos Prepares Underground Shelters With 1,000 Days Remaining

VIVUS, Inc. - VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity